Operating
Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain
Year-over-year, this metric declined by 100.0%, from $97M to $0.
Analysis
StatementCash Flow Statement
SectionOperating
First reportedQ1 2023
Last reportedQ1 2026Apr 29, 2026
Metric ID:
operating_business_combination_step_acquisition_equity_i_c6176bHistorical Data
13 periods
| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $97M | $0 | $0 | $0 | $0 |
| QoQ Change | — | — | — | — | — | — | — | — | — | -100.0% | — | — | — |
| YoY Change | — | — | — | — | — | — | — | — | — | — | — | — | -100.0% |
Range$0 – $97M
Avg YoY Growth-100.0%
Median YoY Growth-100.0%
Frequently Asked Questions
- What is GE HealthCare Technologies's business combination step acquisition equity interest in acquiree remeasurement gain?
- GE HealthCare Technologies (GEHC) reported business combination step acquisition equity interest in acquiree remeasurement gain of $0 in Q1 2026.
- How has GE HealthCare Technologies's business combination step acquisition equity interest in acquiree remeasurement gain changed year-over-year?
- GE HealthCare Technologies's business combination step acquisition equity interest in acquiree remeasurement gain decreased by 100.0% year-over-year, from $97M to $0.